drugset / Trial / NCT06669429

A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjects

NCT06669429 ↗

Phase 1 Recruiting 72 enrolled Peking University First Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the safety, tolerability, pharmacokinetics, pharmacodynamics and food effects of RS-C1001 tablets in Chinese healthy subjects. This study will consist of two parts (Parts A and B). 42 subjects have been planned for Part A and 30 subjects for Part B.

Timeline

Start
2024-09-25
Primary completion
2025-06-30
Completion
2025-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject RS-C1001 Unknown 50 mg Oral

Indications